4.5 Article

S-acylation of influenza virus proteins: Are enzymes for fatty acid attachment promising drug targets?

Journal

VACCINE
Volume 33, Issue 49, Pages 7002-7007

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2015.08.095

Keywords

Influenza virus; HA; M2; Palmitoylation; DHHC-protein; Drug target

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [740 (TP C3), Ve 141/10-1]

Ask authors/readers for more resources

Covalent attachment of saturated fatty acids (palmitate and stearate) to hemagglutinin (HA) of influenza virus is a protein modification essential for viral replication. The enzymes catalysing acylation of viral proteins have not been identified, but likely candidates that acylate cellular substrates are members of a protein family that contain a DHHC (Asp-His-His-Cys) cysteine-rich domain. Since 23 DHHC-proteins with distinct, only partly overlapping substrate specificities are present in humans, only a few of them might acylate HA in airway cells of the lung. We argue here that these DHHC-proteins might be promising drug targets since their blockade should result in suppression of viral replication, while acylation of cellular proteins will not be (or very little) compromised. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available